Austrian COVID-19 Registry
AGMT_COVID-19 Registry
Synopsis
Short title: AGMT_COVID-19 Registry
Title: Austrian COVID-19 Registry
Status: open
Start: April 2020
Coordinating Investigator: Univ. Prof. Dr. Richard Greil
NIS Number: NIS008028
ClinicalTrialsID: NCT04351529
Number of patients: 1000 (planned)
Sponsor: AGMT gemeinnützige GmbH
Design
The AGMT_COVID-19 Registry is designed as multicenter observational cohort of patients, that are tested positive for SARS-CoV-2. Data will be collected from all sites in Austria willing to participate.
Due to the non-interventional nature of the AGMT_COVID-19 registry, only routine data, which has already been recorded in the patient’s medical chart, is transferred to the eCRF. Treatment indication, the decision to offer treatment, treatment choice, dose, schedule and dose reductions/escalations, and response assessments shall be exclusively based on the risk/benefit estimation of the treating physician.
An estimated 1000 patients are expected to be included; these numbers may be revised over time as interest and demand dictates.
Objectives:
To assess the clinical and treatment patterns of patients with COVID-19.
Inclusion/Exclusion Criteria
Inclusion Criteria:
Physicians will select appropriate patients for enrollment. Appropriate patients are expected to:
- Age >18 years
- Positive test for SARS-CoV-2
Due to the non-interventional design of the registry there are no specific inclusion or exclusion criteria.
Participation in the registry must not interfere with diagnostic and/or therapeutic decision making.